It's Fusion As Jazz Pharmaceuticals, Azur Pharma Reach Merger Agreement

The maker of narcolepsy drug Xyrem gets a portfolio of CNS and women's health drugs while moving its headquarters to Ireland, saving millions on taxes.

More from Archive

More from Pink Sheet